ArticleHeart rhythm O22025
Newly diagnosed atrial fibrillation detected by noninvasive screening methods in clinical practice.
Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patient characteristics and outcomes of newly diagnosed atrial fibrillation (AF) have been investigated in large registries. Objective: The study aimed to address the role of non-invasive screening tools in diagnosing AF in the Argentinian clinical practice. Methods: This was an observational retrospective study. Patients' clinical characteristics and management of newly diagnosed AF detected by a non-invasive screening tool were analyzed. Results: Of 12,635 AF outpatients, 1018/5947 (17.1%) of newly diagnosed AF were detected by a screening method: electrocardiography monitoring device (82.3%), self-pulse palpation (17.3%), and smartwatch/smartphone (0.4%).Screening (+) patients were older (73 years [63-81] vs 72 [65-81], Conclusion: Non-invasive screening tools are mainly used in Argentinian clinical practice to detect AF in asymptomatic patients at high risk of thromboembolic and bleeding complications. Vitamin K antagonists are less prescribed, and electrical cardioversion is preferred over antiarrhythmic drugs for initial rhythm control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.